Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Sagimet Biosciences Inc SGMT

Healthcare Biotechnology
Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic pathways in diseases resulting from the overproduction of the fatty acid, palmitate. The Company's lead drug candidate, denifanstat, is an oral, once-daily pill and the selective FASN inhibitor... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SGMT)

Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 23, 2024

GlobeNewswire 3 days ago

Sagimet Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates

GlobeNewswire 4 days ago

Sagimet Announces Oral Presentation of Data from the Phase 2b FASCINATE-2 Study of Denifanstat in MASH at EASL International Liver Congress 2024

GlobeNewswire 12 days ago

Sagimet Biosciences Announces Appointment of Thierry Chauche as Chief Financial Officer

GlobeNewswire 13 days ago

Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 3, 2024

GlobeNewswire April 22, 2024

Sagimet Biosciences Announces Completion of Phase 1 Hepatic Impairment Study with FASN Inhibitor Denifanstat

GlobeNewswire March 27, 2024

Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors

GlobeNewswire March 25, 2024

Sagimet Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates

GlobeNewswire March 25, 2024

Sagimet Biosciences to Participate in Two Upcoming Investor Conferences

GlobeNewswire February 29, 2024
View More News ››

Opinion & Analysis (NDAQ:SGMT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SGMT)

SGMT..... Scalped

Cheers !!!!
Iseneschal - January 22, 2024

SGMT....$13.69 crucial support now

It better pick up and vols increase
Iseneschal - January 22, 2024

RE:SGMT....has to rip over $16 for me to buy

Possible tank...now sub 14
Iseneschal - January 22, 2024

SGMT....draw a line from ~ $6 to where its at now

Thats called a RBL Better stay above or its all over
Iseneschal - January 22, 2024

SGMT....has to rip over $16 for me to buy

I see this tanking
Iseneschal - January 22, 2024

SGMT....and now for the "Ugly"

Waiting for the gap south?
Iseneschal - January 22, 2024
View more Bullboard ››

Xcyte Digital Corp.

Xcyte Digital Corp.

Xcyte Digital is a virtual event company focused on simplifying the event hosting industry and expanding event hosting ...
View More »